The Pilot and Feasibility Program is directed by Atul Bhan. In this role, Dr. Bhan will evaluate letters of intent for suitability, assist the Center director with identification of appropriate reviewers, and examine reviews received. Dr. Bhan is charged specifically with reviewing these initial funding proposals in the context of the overall programmatic goals of the Center in fostering new digestive disease investigators and advancing understanding of IBD. He will also chair the meeting of the CSIBD Executive Steering Committee that ranks the proposals for funding.
The specific aims of the Pilot and Feasibility Program are to (1) recruit new investigators into IBD research by providing funding for IBD related nascent research programs, and (2) generate new ideas related to IBD research by providing funding for innovative high risk high payoff lines of investigation. As detailed in the Research Strategy of this program, achievement of these goals is evident in the success that P/F recipients have had in bringing pilot projects to the juncture at which they have led to ongoing research funding by external peer-reviewed agencies as well as results warranting publication in peer-reviewed journals. In the last ten years of funding (2005-2014), 35 Pilot and Feasibility Program award recipients have gone on to become independent investigators; 10 of these transitions to independence occurred since the last competing renewal in 2009.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
5P30DK043351-30
Application #
9848619
Study Section
Special Emphasis Panel (ZDK1)
Project Start
Project End
Budget Start
2020-01-01
Budget End
2020-12-31
Support Year
30
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
073130411
City
Boston
State
MA
Country
United States
Zip Code
02114
Angelini, Alessandro; Miyabe, Yoshishige; Newsted, Daniel et al. (2018) Directed evolution of broadly crossreactive chemokine-blocking antibodies efficacious in arthritis. Nat Commun 9:1461
Franzosa, Eric A; McIver, Lauren J; Rahnavard, Gholamali et al. (2018) Species-level functional profiling of metagenomes and metatranscriptomes. Nat Methods 15:962-968
Khalaf, Natalia; Yuan, Chen; Hamada, Tsuyoshi et al. (2018) Regular Use of Aspirin or Non-Aspirin Nonsteroidal Anti-Inflammatory Drugs Is Not Associated With Risk of Incident Pancreatic Cancer in Two Large Cohort Studies. Gastroenterology 154:1380-1390.e5
McDonald, Daniel; Hyde, Embriette; Debelius, Justine W et al. (2018) American Gut: an Open Platform for Citizen Science Microbiome Research. mSystems 3:
Goodman, Russell P; Calvo, Sarah E; Mootha, Vamsi K (2018) Spatiotemporal compartmentalization of hepatic NADH and NADPH metabolism. J Biol Chem 293:7508-7516
Mashayekhi, Rouzbeh; Bellavance, Danielle R; Chin, Samantha M et al. (2018) Obesity, but Not Physical Activity, Is Associated With Higher Prevalence of Asymptomatic Diverticulosis. Clin Gastroenterol Hepatol 16:586-587
Cushing, Kelly C; Kordbacheh, Hamed; Gee, Michael S et al. (2018) Sarcopenia is a Novel Predictor of the Need for Rescue Therapy in Hospitalized Ulcerative Colitis Patients. J Crohns Colitis :
Vatanen, Tommi; Plichta, Damian R; Somani, Juhi et al. (2018) Genomic variation and strain-specific functional adaptation in the human gut microbiome during early life. Nat Microbiol :
Su, C; Su, L; Li, Y et al. (2018) Helminth-induced alterations of the gut microbiota exacerbate bacterial colitis. Mucosal Immunol 11:144-157
Merkulova, Maria; P?unescu, Teodor G; Nair, Anil V et al. (2018) Targeted deletion of the Ncoa7 gene results in incomplete distal renal tubular acidosis in mice. Am J Physiol Renal Physiol 315:F173-F185

Showing the most recent 10 out of 1166 publications